Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$381M |
| 2 |
Philip Morris
PM
|
+$339M |
| 3 |
DuPont de Nemours
DD
|
+$270M |
| 4 |
Altria Group
MO
|
+$268M |
| 5 |
Fox Class A
FOXA
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$513M |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$362M |
| 3 |
Merck
MRK
|
+$350M |
| 4 |
FITB
Fifth Third Bancorp
FITB
|
+$277M |
| 5 |
Pfizer
PFE
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Financials | 12.8% |
| 3 | Consumer Discretionary | 11.91% |
| 4 | Healthcare | 10.98% |
| 5 | Communication Services | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Integer Holdings
ITGR
$4.12B
| $69.7M | 0.02% |
924,551
-81,133
| -8% | -$6.64M |
|
677
Jefferies Financial Group
JEF
$12.6B
| $69.7M | 0.02% |
4,141,370
+220,989
| +6% | +$3.9M |
|
678
Allegion
ALLE
$13.4B
| $69.6M | 0.02% |
767,831
+78,161
| +11% | +$6.8M |
|
|
SCHW
679
Charles Schwab
SCHW
$183B
| $69.3M | 0.02% |
1,621,743
+73,202
| +5% | +$3.3M |
|
680
Invesco Equal Weight 0-30 Year Treasury ETF
GOVI
$1.22B
| $69.1M | 0.02% |
2,104,703
+170,609
| +9% | +$5.47M |
|
681
EPR Properties
EPR
$4.75B
| $69M | 0.02% |
897,832
+82,971
| +10% | +$6.04M |
|
682
Quest Diagnostics
DGX
$25.7B
| $69M | 0.02% |
767,780
+19,037
| +3% | +$1.65M |
|
683
Canadian Imperial Bank of Commerce
CM
$108B
| $69M | 0.02% |
1,745,972
-387,226
| -18% | -$16.1M |
|
684
Packaging Corp of America
PKG
$21.9B
| $69M | 0.02% |
694,567
-100,194
| -13% | -$9.52M |
|
685
Carlisle Companies
CSL
$14.6B
| $69M | 0.02% |
562,389
-68,114
| -11% | -$7.86M |
|
686
Wolverine World Wide
WWW
$1.61B
| $68.9M | 0.02% |
1,929,599
-54,207
| -3% | -$1.89M |
|
|
AERI
687
DELISTED
Aerie Pharmaceuticals
AERI
| $68.9M | 0.02% |
1,450,945
+352,638
| +32% | +$15.5M |
|
688
RLI Corp
RLI
$5.62B
| $68.9M | 0.02% |
1,920,616
+221,038
| +13% | +$7.62M |
|
689
TripAdvisor
TRIP
$1.65B
| $68.8M | 0.02% |
1,336,400
+159,295
| +14% | +$8.73M |
|
|
ABMD
690
DELISTED
Abiomed Inc
ABMD
| $68.4M | 0.02% |
239,601
+32,702
| +16% | +$10.9M |
|
691
AstraZeneca
AZN
$263B
| $68.4M | 0.02% |
845,594
-5,540
| -0.7% | -$437K |
|
692
Cognex
CGNX
$10.9B
| $68.2M | 0.02% |
1,339,982
-3,103
| -0.2% | -$149K |
|
693
Nektar Therapeutics
NKTR
$2.39B
| $67.7M | 0.02% |
134,419
+13,929
| +12% | +$8.25M |
|
694
Halozyme
HALO
$9.79B
| $67.7M | 0.02% |
4,203,858
-10,256
| -0.2% | -$166K |
|
|
GWPH
695
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $67.6M | 0.02% |
401,299
+49,648
| +14% | +$7.39M |
|
696
BWX Technologies
BWXT
$15.5B
| $67.6M | 0.02% |
1,363,547
+5,453
| +0.4% | +$258K |
|
|
PFPT
697
DELISTED
Proofpoint, Inc.
PFPT
| $67.5M | 0.02% |
555,890
+38,362
| +7% | +$4.21M |
|
|
IFLN
698
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$308M
| $67.4M | 0.02% |
3,614,242
+972,381
| +37% | +$17.9M |
|
699
Oshkosh
OSK
$8.79B
| $67.3M | 0.02% |
896,348
-156,487
| -15% | -$11.6M |
|
700
Integra LifeSciences
IART
$1.29B
| $67.2M | 0.02% |
1,206,089
-2,650
| -0.2% | -$135K |
|
Similar funds
Invesco's Q1 2019 Portfolio in Review
As of Q1 2019, Invesco held 3,988 positions worth $297B, up 14% from $261B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Invesco's Q1 2019 filing shows 172 new, 1,740 increased, 1,658 reduced and 285 closed positions. Its largest new stake was Fox Class A: 4,126,302 shares worth $151M. The largest sale was Twenty-First Century Fox, Inc. Class A, an estimated $513M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Invesco's largest Q1 2019 buy was Fox Class A: 4,126,302 shares worth $151M.
- Invesco added most to Apple in Q1 2019, an estimated $381M increase.
- Invesco's biggest Q1 2019 reduction was Merck, cutting an estimated $350M.
- Invesco fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $513M.
- Invesco's ten largest holdings make up 17% of its $297B portfolio in Q1 2019.
- Invesco opened 172 new positions and closed 285 in Q1 2019.
- Invesco's portfolio value rose 14% quarter-over-quarter to $297B.
Based on Invesco's 13F filing for Q1 2019, filed 15 May 2019.